BioAge Labs, Inc.
BIOA$474M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaEMERYVILLE
Drugs in Pipeline
5
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
BIOA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
FG-4592
Anemia
N1539
Pain, Postoperative
JOINTSTEM
Degenerative Arthritis
Roxadustat
Chemotherapy Induced Anemia
Brequinar
COVID-19
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
FG-4592 | Phase 3 | Anemia | - | - |
N1539 | Phase 3 | Pain, Postoperative | - | - |
JOINTSTEM | Phase 3 | Degenerative Arthritis | - | - |
Roxadustat | Phase 3 | Chemotherapy Induced Anemia | - | - |
Brequinar | Phase 2 | COVID-19 | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply